Numinus Wellness Inc. (NUMI.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
At close: 03:58PM EDT
| Previous Close | 0.0300 |
| Open | 0.0300 |
| Bid | 0.0300 x N/A |
| Ask | 0.0350 x N/A |
| Day's Range | 0.0300 - 0.0300 |
| 52 Week Range | 0.0300 - 0.2000 |
| Volume | |
| Avg. Volume | 236,413 |
| Market Cap | 9.617M |
| Beta (5Y Monthly) | 1.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings Date | Nov 27, 2024 - Dec 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Baystreet
Stocks in play: Numinus Wellness Inc.
Comments on the U.S. Food and Drug Administration's decision to not approve Lykos Therapeutics' new ...
CNW GroupNuminus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD
Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and evidence-based treatments, comments on the U.S. Food and Drug Administration's ("FDA") decision to not approve Lykos Therapeutics' new drug application for MDMA (midomafetamine capsules) used in combination with psychological intervention for individuals with post-traumatic stress disorder ("PTSD"). According to a news release issued by Lykos Therapeutics,
Simply Wall St.Numinus Wellness Third Quarter 2024 Earnings: Misses Expectations
Numinus Wellness ( TSE:NUMI ) Third Quarter 2024 Results Key Financial Results Revenue: CA$4.35m (down 28% from 3Q...
© 2024 Yahoo. All rights reserved.